Kootenai Cancer Center is a clinical research site located in Coeur d'Alene, Idaho, United States 83814.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Kootenai Cancer Center has participated in 7 clinical trials.
Therapeutic areas: Lymphoma, Non-Hodgkin, Breast Cancer, Soft Tissue Sarcoma.
Sponsors: Pfizer, NSABP Foundation Inc, Celgene.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Kootenai Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kootenai Cancer Center has 7 clinical trials on record. Their work covers Lymphoma, Non-Hodgkin, Breast Cancer, Soft Tissue Sarcoma.
Yes — Kootenai Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.